Our focus allows us to give enhanced attention to specific challenges in biochemical testing and accelerate product development and delivery.

Newborn screening platform for lysosomal storage disorders with FDA authorization and CE mark.

Innovative platform that operates on tiny droplets of blood to rapidly perform time critical tests in various distributed settings.

Related Content